Argenta microspheres for animal health products

A flexible technology to address a range of drug delivery challenges

A successful animal drug delivery system must deliver an active pharmaceutical ingredient (API) to the right target with sufficient bioavailability and over an appropriate time period, all while being safe and tolerable to the animal.

But this can be challenging with traditional drug delivery technologies. 

Conventional delivery systems often offer poor bioavailability and can be tricky to administer to animals, impacting therapy compliance. What is more, with such technologies, achieving extended controlled release can be exceptionally difficult.

That is why animal health companies are increasingly exploring a promising alternative: controlled-release microspheres.

Download our insight-packed microspheres fact sheet and discover:

• What microspheres are
• All about Argenta’s licensable microspheres technology, including its key specifications
• How our microspheres can help you overcome some of the toughest drug delivery challenges — from poor bioavailability to uncontrolled API release
• The range of APIs, administration routes, species, and indications for which our microspheres are suitable
• How Argenta can help speed the path from 'molecule to market' for microspheres-based therapies

Argenta delivers high-quality products and services to our global animal health and nutrition partners. Our unique 'molecule to market' approach means that we can partner comprehensively across a product's complete development cycle or step in where we add the most value — from concept to commercialisation.